摘要
本研究对比观察Knoll产普罗帕酮(rytomonorm)片(R)与国产普罗帕酮片(D)在8名中国男性健康志愿者体内的生物利用度及代谢变化。采用同体随机交叉法将志愿者分成口服A与B及静脉组。每组4人。A、B组分别单剂口服R与D150mg和300mg。血清普罗帕酮(PF)及代谢物5-羟普罗帕酮(5-OHP)与N-去丙基普罗帕酮(NDPP)用反相HPLC方法测定。结果表明R与D绝对生物利用度分别是44.00±31.78%与30.92±27.36%(P<0.02),R/D的相对生物利用度是235±195%。A、B组PF的AUC及Cmax均是R大于D,相差有显著性。R与D制剂的血浓度与剂量均呈非线性关系。静脉组未测得代谢物。A组5-OHP的Cmax与AUC接近或大于PF,B组为PF的50%。NDPP只在B组测到,其Cmax为PF的5%。以上提示单剂口服给药R制剂的生物利用度大于D制剂。PF主要代谢成5-OHP,5-OHP的抗心律失常作用应予重视。
Comparative study on the bioavailability and metabolism of rytomonorm (R)and domestic propafenone(D)tablets wax performed in eight healthy volunteers. A randomized, single-blind,cross-over study was adopted .The eight volunteers were randomly divided into oral group A, B and i. v. group, each group consisted of four persons.Group A and B took single oral dose of 150 mg and 300 mg respectively (both R and D).The i. v.group received 35 mg dose of intravenous R The washout period between experiments in the same volunteer was two weeks. Serum concentration of propafenone (PF) 5-hydroxypropafenone (5-OHP)and N-depropylpropafenone (NDPP) were measured by HPLC method.The mean (±SD) absolute bioavailability values of R and D were 44.00 ±15. 86%, 30.92 ±13.68 % respectively(P<0. 02). The mean relative bioavailability of R/D was 235 ±195%. For AUC0-24 and Cmax of PF, R was significangly greater than D both A and B groups. The curve of serum concentration of PF with dose in R and D was nonlinear. The metabolites cannot be measured in i. v. group.The all eight healthy volunteers were extensive metabolizers. The mean Cmax and AUC0-24 ratios of 5-OHP/PPF for R vs D were 1.13±1.06 vs 3.11±2.55 (P>0.05) and 0.82±0.50 vs3.01±2.28 (P>0.05) in the group A,were 0. 40±0.23 vs 0.50±0.33 (P>0.05) and 0.33±0. 18 vs 0.52±0.24 (P>0.05) in the group B.The concentrations of NDPP were only measured in the group B and the mean Cmax ratios of NDPP/PPF for R and D were 0.05 ±0.03 and 0.06 ±0.01 (P>0. 05). Our data suggest that the bioavailabitily of Rytomonorn is higher than domestic propafenone and that propafenone is maintly metabolized to 5-hydroxypropafenone after single oral doses in Chinese,so antiarrhythmic activity of 5-OHP in extensive metabolizers should be considered.
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
1995年第1期38-44,共7页
The Chinese Journal of Clinical Pharmacology